Circulation, Vol 84, 558-566, Copyright © 1991 by American Heart Association
JH Levine, ED Mellits, RA Baumgardner, EP Veltri, M Mower, L Grunwald, T Guarnieri, D Aarons and LS Griffith
BACKGROUND. Two hundred eighteen patients were evaluated in a two-phase
approach (time to first appropriate discharge, survival after discharge) to
identify factors that may be related to maximal benefit derived from use of
an automatic implantable cardioverter-defibrillator (AICD). METHODS AND
RESULTS. One hundred ninety-seven patients survived implantation of AICD,
with or without concomitant cardiac surgery. One hundred five patients had
an AICD discharge associated with syncope, presyncope, documented sustained
ventricular tachycardia or fibrillation, or sleep at 9.1 +/- 11.1 months
after implantation. Patients survived 23.8 +/- 18.0 months after AICD
discharge. Left ventricular dysfunction (p = 0.008 for ejection fraction
less than 25%) was associated with earlier AICD discharge and shortened
survival after AICD discharge (p = 0.008 for ejection fraction less than
25%; p = 0.01 for New York Heart Association functional class III and IV).
beta- Blocker administration (p = 0.006) and coronary bypass surgery (p =
0.06) were associated with later AICD discharge. Coronary bypass surgery (p
= 0.035) but not beta-blockers was associated with more prolonged survival
after AICD discharge. CONCLUSIONS. These data suggest that a relatively
easy algorithm can be applied to predict which patient will benefit most
from AICD implantation.
ARTICLES
Predictors of first discharge and subsequent survival in patients with automatic implantable cardioverter-defibrillators
Division of Cardiology, Johns Hopkins Medical Institutions, Baltimore, Md.
This article has been cited by other articles:
 |
|
 |
|
  S. Knecht, F. Sacher, M. Wright, M. Hocini, A. Nogami, T. Arentz, B. Petit, R. Franck, C. De Chillou, D. Lamaison, et al. Long-term follow-up of idiopathic ventricular fibrillation ablation: a multicenter study. J. Am. Coll. Cardiol., August 4, 2009; 54(6): 522 - 528. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 Task force members, J. Vijgen, G. Botto, J. Camm, C.-J. Hoijer, W. Jung, J.-Y. Le Heuzey, A. Lubinski, T. M. Norekval, M. Santomauro, et al. Consensus statement of the European Heart Rhythm Association: updated recommendations for driving by patients with implantable cardioverter defibrillators Europace, August 1, 2009; 11(8): 1097 - 1107. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
G. Klein, C. Lissel, A.-C. Fuchs, A. Gardiwal, H. Oswald, M. deSousa, A. M. Pichlmaier, R. Lichtinghagen, H. Geerlings, P. Lippolt, et al. Predictors of VT/VF-occurrence in ICD patients: results from the PROFIT-Study. Europace, August 1, 2006; 8(8): 618 - 624. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 E. Vanoli and P. B. Adamson What does the future hold for the management of chronic heart failure? Eur. Heart J. Suppl., June 1, 2006; 8(suppl_C): C51 - C57. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A Verma, F Kilicaslan, D O Martin, S Minor, R Starling, N F Marrouche, S Almahammed, O M Wazni, S Duggal, R Zuzek, et al. Preimplantation B-type natriuretic peptide concentration is an independent predictor of future appropriate implantable defibrillator therapies Heart, February 1, 2006; 92(2): 190 - 195. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. P. Singh, W. J. Hall, S. McNitt, H. Wang, J. P. Daubert, W. Zareba, J. N. Ruskin, A. J. Moss, and and the MADIT-II Investigators Factors Influencing Appropriate Firing of the Implanted Defibrillator for Ventricular Tachycardia/Fibrillation: Findings From the Multicenter Automatic Defibrillator Implantation Trial II (MADIT-II) J. Am. Coll. Cardiol., November 1, 2005; 46(9): 1712 - 1720. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 W. Whang, M. A. Mittleman, D. Q. Rich, P. J. Wang, J. N. Ruskin, G. H. Tofler, J. E. Muller, C. M. Albert, and for the TOVA Investigators Heart Failure and the Risk of Shocks in Patients With Implantable Cardioverter Defibrillators: Results From the Triggers Of Ventricular Arrhythmias (TOVA) Study Circulation, March 23, 2004; 109(11): 1386 - 1391. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 V. Vijay and J. P. Gold Late Complications of Cardiac Surgery Card. Surg. Adult, January 1, 2003; 2(2003): 521 - 537. [Full Text]
|
|
|
|
|
|
S. E. Sandner, G. Wieselthaler, A. Zuckermann, S. Taghavi, H. Schmidinger, R. Pacher, M. Ploner, G. Laufer, E. Wolner, and M. Grimm Survival Benefit of the Implantable Cardioverter-Defibrillator in Patients on the Waiting List for Cardiac Transplantation Circulation, September 18, 2001; 104 (2009): I-171 - I-176. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S.G. Priori, E. Aliot, C. Blomstrom-Lundqvist, L. Bossaert, G. Breithardt, P. Brugada, A.J. Camm, R. Cappato, S.M. Cobbe, C. Di Mario, et al. Task Force on Sudden Cardiac Death of the European Society of Cardiology Eur. Heart J., August 2, 2001; 22(16): 1374 - 1450. [PDF]
|
|
|
|
|
|
N. A. Freedberg, J. N. Hill, R. I. Fogel, E. N. Prystowsky, and the CARE Group Recurrence of symptomatic ventricular arrhythmias in patients with implantable cardioverter defibrillator after the first device therapy: Implications for antiarrhythmic therapy and driving restrictions J. Am. Coll. Cardiol., June 1, 2001; 37(7): 1910 - 1915. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. De Sutter, R. Tavernier, M. De Buyzere, L. Jordaens, and G. De Backer Lipid lowering drugs and recurrences of life-threatening ventricular arrhythmias in high-risk patients J. Am. Coll. Cardiol., September 1, 2000; 36(3): 766 - 772. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
K.-H. Kuck, R. Cappato, J. Siebels, and R. Ruppel Randomized Comparison of Antiarrhythmic Drug Therapy With Implantable Defibrillators in Patients Resuscitated From Cardiac Arrest : The Cardiac Arrest Study Hamburg (CASH) Circulation, August 15, 2000; 102(7): 748 - 754. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. V. Exner, J. A. Reiffel, A. E. Epstein, R. Ledingham, M. J. Reiter, Q. Yao, H. J. Duff, D. Follmann, E. Schron, H. L. Greene, et al. Beta-blocker use and survival in patients with ventricular fibrillation or symptomatic ventricular tachycardia: the antiarrhythmics versus implantable defibrillators (AVID) trial J. Am. Coll. Cardiol., August 1, 1999; 34(2): 325 - 333. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
L. Mont, M. Valentino, A. Sambola, M. Matas, L. Aguinaga, and J. Brugada Arrhythmia recurrence in patients with a healed myocardial infarction who received an implantable defibrillator: analysis according to the clinical presentation J. Am. Coll. Cardiol., August 1, 1999; 34(2): 351 - 357. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
V. Kuhlkamp, C. Mewis, J. Mermi, R. F. Bosch, and L. Seipel Suppression of sustained ventricular tachyarrhythmias: a comparison of d,l-sotalol with no antiarrhythmic drug treatment J. Am. Coll. Cardiol., January 1, 1999; 33(1): 46 - 52. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. T. Bigger and The Coronary Artery Bypass Graft (CABG) Patch Tria Prophylactic Use of Implanted Cardiac Defibrillators in Patients at High Risk for Ventricular Arrhythmias after Coronary-Artery Bypass Graft Surgery N. Engl. J. Med., November 27, 1997; 337(22): 1569 - 1575. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. A. Strickberger, K. C. Man, E. G. Daoud, R. Goyal, K. Brinkman, C. Hasse, F. Bogun, B. P. Knight, R. Weiss, M. Bahu, et al. A Prospective Evaluation of Catheter Ablation of Ventricular Tachycardia as Adjuvant Therapy in Patients With Coronary Artery Disease and an Implantable Cardioverter-Defibrillator Circulation, September 2, 1997; 96(5): 1525 - 1531. [Abstract] [Full Text]
|
|
|
|
|
|
A. J. Moss, W. J. Hall, D. S. Cannom, J. P. Daubert, S. L. Higgins, H. Klein, J. H. Levine, S. Saksena, A. L. Waldo, D. Wilber, et al. Improved Survival with an Implanted Defibrillator in Patients with Coronary Disease at High Risk for Ventricular Arrhythmia N. Engl. J. Med., December 26, 1996; 335(26): 1933 - 1940. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
G. J. Fahy, E. B. Sgarbossa, P. J. Tchou, and S. L. Pinski Hospital Readmission in Patients Treated With Tiered-Therapy Implantable Defibrillators Circulation, September 15, 1996; 94(6): 1350 - 1356. [Abstract] [Full Text]
|
|
|
|
|
|
A. E. Epstein, W. M. Miles, D. G. Benditt, A. J. Camm, E. J. Darling, P. L. Friedman, A. Garson, J. C. Harvey, G. A. Kidwell, G. J. Klein, et al. Personal and Public Safety Issues Related to Arrhythmias That May Affect Consciousness: Implications for Regulation and Physician Recommendations: A Medical/Scientific Statement From the American Heart Association and the North American Society of Pacing and Electrophysiology Circulation, September 1, 1996; 94(5): 1147 - 1166. [Full Text]
|
|
|
|
|
|
J. Villacastin, J. Almendral, A. Arenal, J. Albertos, J. Ormaetxe, R. Peinado, H. Bueno, J. L. Merino, A. Pastor, O. Medina, et al. Incidence and Clinical Significance of Multiple Consecutive, Appropriate, High-Energy Discharges in Patients With Implanted Cardioverter-Defibrillators Circulation, February 15, 1996; 93(4): 753 - 762. [Abstract] [Full Text]
|
|
|
|
|
|
M. R. Costanzo, S. Augustine, R. Bourge, M. Bristow, J. B. O'Connell, D. Driscoll, and E. Rose Selection and Treatment of Candidates for Heart Transplantation : A Statement for Health Professionals From the Committee on Heart Failure and Cardiac Transplantation of the Council on Clinical Cardiology, American Heart Association Circulation, December 15, 1995; 92(12): 3593 - 3612. [Abstract] [Full Text]
|
|
|
|
 |
|
 D. M. Shahian, W. A. Williamson, F. J. Venditti Jr., D. T. Martin, and J. R. Ellis THE ROLE OF CORONARY REVASCULARIZATION IN RECIPIENTS OF AN IMPLANTABLE CARDIOVERTER-DEFIBRILLATOR J. Thorac. Cardiovasc. Surg., October 1, 1995; 110(4): 1013 - 1022. [Abstract] [Full Text]
|
|
|
|
 |
|
 J. Gardiner, A. Hogan, M. Holmes-Rovner, D. Rovner, L. Griffith, and J. Kupersmith Confidence Intervals for Cost - Effectiveness Ratios Med Decis Making, August 1, 1995; 15(3): 254 - 263. [Abstract] [PDF]
|
|
|
|
|
|
E. J. Rashba, M. Cooklin, K. MacMurdy, N. Kavesh, M. Kirk, S. Sarang, R. W. Peters, S. R. Shorofsky, and M. R. Gold Effects of Selective Autonomic Blockade on T-Wave Alternans in Humans Circulation, February 19, 2002; 105(7): 837 - 842. [Abstract] [Full Text] [PDF]
|
|